REMSEQ
Dead / Abandoned — Abandoned — no statement of use filed (as of 06 Nov 2023)
What this means for you
This application is over — abandoned 06 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88692773
- Mark type
- Stylized text
- Filed
- 14 Nov 2019
- Published for opposition
- 11 Aug 2020
- Abandoned
- 06 Nov 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and therapeutic preparations for the treatment of cancer, immune system related diseases and disorders, cardiovascular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
- Class 042 — Scientific and technological services: pharmaceutical, medical, scientific, and biopharmaceutical research and development
Owner
- Remix Therapeutics Inc., Cambridge, MA, US
- Remix Therapeutics Inc., Cambridge, MA, US
Prosecution history
- 06 Nov 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 06 Nov 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Apr 2023 — SOU EXTENSION 5 GRANTED
- 06 Apr 2023 — SOU EXTENSION 5 FILED
- 13 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 06 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Oct 2022 — SOU EXTENSION 4 GRANTED
- 04 Oct 2022 — SOU EXTENSION 4 FILED
- 04 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 07 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Apr 2022 — SOU EXTENSION 3 GRANTED
- 05 Apr 2022 — SOU EXTENSION 3 FILED
- 05 Apr 2022 — SOU TEAS EXTENSION RECEIVED